ELIZABETH SHPALL to Leukemia, Myelomonocytic, Chronic
This is a "connection" page, showing publications ELIZABETH SHPALL has written about Leukemia, Myelomonocytic, Chronic.
Connection Strength
0.063
-
Impact of frontline treatment approach on outcomes in patients with secondary AML with prior hypomethylating agent exposure. J Hematol Oncol. 2022 01 29; 15(1):12.
Score: 0.037
-
Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning. Cancer. 2017 Jul 15; 123(14):2661-2670.
Score: 0.026